Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia-Reference-Cited by-同舟云学术

Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia

Published:2014-07-24 Issue: Volume:29 Page:1-9
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Sievert William¹,Razavi Homie²,Estes Chris²,Thompson Alexander J³,Zekry Amany⁴,Roberts Stuart K⁵,Dore Gregory J⁶

Affiliation:

1. Monash University and Monash Health; Melbourne Victoria Australia

2. Center for Disease Analysis; Louisville Colorado USA

3. St Vincent's Hospital and the University of Melbourne; Melbourne Victoria Australia

4. St George Hospital; Sydney New South Wales Australia

5. The Alfred Hospital; Melbourne Victoria Australia

6. Kirby Institute; UNSW Australia; Sydney New South Wales Australia

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12677/fullpdf

Reference38 articles.

1. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies;Micallef;J. Viral Hepat.,2006

2. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression;Thein;Hepatology,2008

3. The Kirby Institute for Infection and Immunity in Society HIV, viral hepatitis and sexually transmissible infections in Australia. Annual Surveillance Reports 1997-2013 2014 http://kirby.unsw.edu.au/surveillance/Annual-Surveillance-Reports

4. Modelling the hepatitis C virus epidemic in Australia;Razali;Drug Alcohol Depend.,2007

5. Hepatitis C treatment outcomes in Australian clinics;Gidding;Med. J. Aust.,2012

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Publisher's Note;International Journal of Drug Policy;2024-09

2. Direct-Acting Antivirals Remain Cost-Effective Treatments for Chronic Hepatitis C in Australia Despite Changes to the Treated Population and the Availability of Retreatment: The Glecaprevir/Pibrentasvir (Maviret®) Example;Infectious Diseases and Therapy;2024-03

3. The Role of Social Science in Hepatitis;Handbook of Social Sciences and Global Public Health;2023

4. The Role of Social Science in Hepatitis;Handbook of Social Sciences and Global Public Health;2023

5. Hepatocellular carcinoma (HCC) is changing its face: analysis of the temporal trends in aetiology and clinical patterns of HCC in South Australia;Internal Medicine Journal;2022-08-30